J.P. Morgan Annual Healthcare Conference, San Francisco, USA - Shorla Oncology: A Leader in Innovative Oncology Solutions

LATEST NEWS

Shorla Oncology Announces FDA Filing Acceptance of New Drug Application to Treat Certain Forms of Leukemia and Other Cancers

April 8th 2024

We are delighted to be attending the HOPA 2024 conference at Tampa Florida from 3-6 April. We are looking forward to meeting you at Booth #620.

March 26th 2024

Shorla Oncology Achieves Great Place to Work Certification

March 26th 2024

FDA Receives New Drug Application for SH-105 in Breast and Ovarian Cancer

January 15th 2024

OncLive/ SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer

January 15th 2024

Targeted Oncology/ FDA Ok’s NDA for SH-105 in Breast and Ovarian Cancer

January 15th 2024

Pharmaceutical Executive/ FDA Accepts New Drug Application for Shorla Oncology’s Novel Treatment for Breast, Ovarian Cancer

January 12th 2024

Shorla Oncology Announces FDA Filing Acceptance of New Drug Application for novel formulation to treat breast and ovarian cancer

January 9th 2024

Shorla Oncology attending JP Morgan Healthcare Conference

December 8th 2023